Palliative Coverage Drug Benefit Supplement
|
|
|
- Leslie Clarke
- 8 years ago
- Views:
Transcription
1 Palliative Coverage Drug Benefit Supplement Effective April 1, 2015
2 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross Street NW Edmonton AB T5J 3C5 Telephone Number: (780) (Edmonton) (403) (Calgary) (Toll Free) FAX Number: (780) (Toll Free) 109BWebsite: Administered by Alberta Blue Cross on behalf of Alberta Health. The Drug Benefit List (DBL) is a list of drugs for which coverage may be provided to program participants. The DBL is not intended to be, and must not be used as a diagnostic or prescribing tool. Inclusion of a drug on the DBL does not mean or imply that the drug is fit or effective for any specific purpose. Prescribing professionals must always use their professional judgment and should refer to product monographs and any applicable practice guidelines when prescribing drugs. The product monograph contains information that may be required for the safe and effective use of the product. Copies of the Alberta Drug Benefit List Publication are available from Pharmacy Services, Alberta Blue Cross at the address shown above. Binder and contents: ( G.S.T.) Contents only: ( G.S.T.) A cheque or money order must accompany the request for copies. Changes may be made, without notice, to the List/Supplement through the on-line interactive List/Supplement, and any such changes to the on-line interactive List/Supplement are effective the date of the change (unless otherwise stated) and regardless of the date of publication in the paper version or updates. Please visit for the most current Palliative Coverage Drug Benefit Supplement information. ABC 40211/81160 (R2015/04)
3 Table of Contents PALLIATIVE COVERAGE DRUG BENEFIT SUPPLEMENT SECTION 1 - INTRODUCTION AND THERAPEUTIC CLASSIFICATION OF DRUGS Introduction Eligibility... i Notes... i Price Policy... i Interchangeable Drug Products... i Excluded Special Authorization Drug Products... ii Pharmacologic-Therapeutic Classification of Drugs 10:00 Antineoplastic Agents :00 Central Nervous System Drugs :00 Electrolytic, Caloric, and Water Balance :00 Gastrointestinal Drugs :00 Local Anesthetics... 4 APPENDICES Appendix 1 - Pharmaceutical Manufacturers... 5 Appendix 2 - Alphabetical List of Pharmaceutical Products... 6 Appendix 3 - Numerical List by Drug Identification Number... 8 EFFECTIVE APRIL 1, 2015 i
4 SECTION 1 Introduction and Therapeutic Classification of Drugs Section 1 Introduction and Therapeutic Classification of Drugs
5 INTRODUCTION Eligibility Benefits for Palliative Coverage are defined by the Alberta Drug Benefit List and the Palliative Coverage Drug Benefit Supplement (which defines select hydrating agents, laxatives and other products as additional benefits). In order for patients to be eligible for Palliative Coverage, an application for the Palliative Coverage Program must be completed and signed by both the patient (or guardian) and the physician. This Palliative Coverage Program application form must be forwarded to Alberta Health for their consideration and approval. Notes Palliative Coverage will pay the prescription charge for hydrating agents using the guidelines for injectable drugs as referenced in the Schedule of Prices in Appendix A of the ABC Benefits Corporation Pharmacy Agreement. Price Policy The Price Policy is stated in the Alberta Drug Benefit List. Interchangeable Drug Products A box containing an X ( ) to the left of the DIN or Product Identification Number (PIN) indicates that the product is not interchangeable with other products or interchangeability has not been assessed within the category. Refer to Policies and Guidelines Section 1 of the current Alberta Drug Benefit List for further information regarding interchangeable drug products. EFFECTIVE APRIL 1, 2015 i
6 Excluded Special Authorization Drug Products The following drug product(s) are listed in the special authorization section (Section 3) of the Alberta Drug Benefit List. However, special authorization coverage for these drug product(s) cannot be considered for those patients with Palliative Coverage: Trade Name / Strength / Form Generic Description DIN MFG NEULASTA 6 MG/0.6ML INJECTION SYRINGE PEGFILGRASTIM AMG NEUPOGEN 0.3 MG/ML INJECTION FILGRASTIM AMG Excluded Criteria: To decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppresive anti-neoplastic drugs with curative intent. This drug product must be prescribed by the Directors of Alberta Health Services Cancer Care Cancer Centres (or their designates). EFFECTIVE APRIL 1, 2015 ii.
7 Pharmacologic Therapeutic Classification of Drugs Pharmacologic -Therapeutic Classification of Drugs
8 10:00 ANTINEOPLASTIC AGENTS 10:00 MEGESTROL ACETATE 40 MG ORAL TABLET MEGESTROL 160 MG ORAL TABLET MEGESTROL 40 MG / ML ORAL SUSPENSION MEGACE OS AAP AAP BMS :00 CENTRAL NERVOUS SYSTEM AGENTS 28:08.08 ANALGESICS AND ANTIPYRETICS (OPIATE AGONISTS) FENTANYL 12 MCG/HR TRANSDERMAL PATCH FENTANYL MTX SANDOZ FENTANYL PATCH A-FENTANYL CO FENTANYL MYLAN-FENTANYL MATRIX RAN-FENTANYL MATRIX 25 MCG/HR TRANSDERMAL PATCH FENTANYL MTX SANDOZ FENTANYL PATCH A-FENTANYL APO-FENTANYL CO FENTANYL MYLAN-FENTANYL MATRIX RAN-FENTANYL MATRIX 50 MCG/HR TRANSDERMAL PATCH FENTANYL MTX SANDOZ FENTANYL PATCH A-FENTANYL APO-FENTANYL CO FENTANYL MYLAN-FENTANYL MATRIX RAN-FENTANYL MATRIX 75 MCG/HR TRANSDERMAL PATCH FENTANYL MTX SANDOZ FENTANYL PATCH A-FENTANYL APO-FENTANYL CO FENTANYL MYLAN-FENTANYL MATRIX RAN-FENTANYL MATRIX 100 MCG/HR TRANSDERMAL PATCH FENTANYL MTX SANDOZ FENTANYL PATCH A-FENTANYL APO-FENTANYL 100 CO FENTANYL MYLAN-FENTANYL MATRIX RAN-FENTANYL MATRIX SDZ APH MYP RAN SDZ APX APH MYP RAN SDZ APX APH MYP RAN SDZ APX APH MYP RAN SDZ APX APH MYP RAN UNIT OF ISSUE - REFER TO PRICE POLICY 1 EFFECTIVE APRIL 1, 2015
9 28:00 40:00 56:00 CENTRAL NERVOUS SYSTEM AGENTS 28:08.08 FENTANYL CITRATE 0.05 MG / ML (BASE) INJECTION FENTANYL CITRATE PARENTERAL SOLUTIONS (LARGE & SMALL VOL) INJECTION POTASSIUM CHLORIDE (K+) 149 MG / ML INJECTION POTASSIUM CHLORIDE SODIUM CHLORIDE 0.9 % INJECTION BISACODYL 5 MG ORAL ENTERIC-COATED TABLET APO-BISACODYL APX DULCOLAX BOE Please note: The LCA price indicated for this product is not applicable to clients who are enrolled in the Palliative Care Drug Coverage program. 10 MG RECTAL SUPPOSITORY BISACODYL DULCOLAX BOE Please note: The LCA price indicated for this product is not applicable to clients who are enrolled in the Palliative Care Drug Coverage program. DOCUSATE CALCIUM (OPIATE AGONISTS) ELECTROLYTIC, CALORIC, AND WATER BALANCE 40:12 GASTROINTESTINAL DRUGS 56:12 ANALGESICS AND ANTIPYRETICS REPLACEMENT PREPARATIONS 0.9% SODIUM CHLORIDE 3.3% DEXT/ 0.3% NACL (2/3-1/3) 3.3% DEXT/0.3% NACL/20 MEQ KCL 3.3% DEXT/0.3% NACL/40 MEQ KCL 5% DEXTROSE (D5W) 5% DEXTROSE/ 0.15% KCL 20 MEQ 5% DEXTROSE/ 0.3% KCL 40 MEQ LACTATED RINGER'S SODIUM CHLORIDE CATHARTICS AND LAXATIVES 240 MG ORAL CAPSULE CALAX JAMP-DOCUSATE CALCIUM NOVO-DOCUSATE CALCIUM A-DOCUSATE CALCIUM DOCUSATE CALCIUM SDZ HSP HSP ODN JPC PRODUCT IS NOT INTERCHANGEABLE 2 EFFECTIVE APRIL 1, 2015
10 56:00 GASTROINTESTINAL DRUGS 56:12 DOCUSATE SODIUM 100 MG ORAL CAPSULE SELAX DOCUSATE SODIUM DOCUSATE SODIUM DOCUSATE SODIUM SOFLAX A-DOCUSATE SODIUM APO-DOCUSATE SODIUM NOVO-DOCUSATE SODIUM COLACE 200 MG ORAL CAPSULE SOFLAX 250 MG ORAL CAPSULE SELAX MG / ML ORAL SYRUP RATIO-DOCUSATE SODIUM RPH SELAX ODN COLACE WSP DOCUSATE SODIUM Please note: The LCA price indicated for this product is not applicable to clients who are enrolled in the Palliative Care Drug Coverage program. 50 MG / ML ORAL SYRUP DOCUSATE SODIUM 10 MG / ML ORAL DROPS COLACE WSP POLYETHYLENE GLYCOL G / G ORAL POWDER LAX-A-DAY SENNOSIDES CATHARTICS AND LAXATIVES 8.6 MG ORAL TABLET JAMP-SENNA SENNOSIDES SENNATAB SENNOSIDES SENOKOT 12 MG ORAL TABLET SENNOSIDES SENNOSIDES 1.7 MG / ML ORAL LIQUID JAMP SENNAQUIL 1.7 MG / ML ORAL SYRUP SENOKOT SENNOSIDES/ DOCUSATE SODIUM 8.6 MG * 50 MG ORAL TABLET SENOKOT S SODIUM PHOSPHATE/ SODIUM ACID PHOSPHATE 10.4 G / ENM * 3.9 G / ENM RECTAL ENEMA ENEMOL ODN TAR SNS APX WSP ODN PPH JPC JPC PUR JPC JPC PUR PUR PPH UNIT OF ISSUE - REFER TO PRICE POLICY 3 EFFECTIVE APRIL 1, 2015
11 72:00 LOCAL ANESTHETICS 72:00 BUPIVACAINE HCL 2.5 MG / ML INJECTION SENSORCAINE 5 MG / ML INJECTION SENSORCAINE AZC AZC BUPIVACAINE HCL/ EPINEPHRINE BITARTRATE 2.5 MG / ML * 5 MCG / ML INJECTION SENSORCAINE WITH EPINEPHRINE 5 MG / ML * 5 MCG / ML INJECTION SENSORCAINE WITH EPINEPHRINE AZC AZC PRODUCT IS NOT INTERCHANGEABLE 4 EFFECTIVE APRIL 1, 2015
12 Appendices APPENDICES Pharmaceutical Manufacturers Alphabetical List of Pharmaceutical Products Numerical List by Drug Identification Number
13 Appendix 1: Pharmaceutical Manufacturers AAP APH APX AZC BMS BOE HSP JPC MYP ODN PPH PUR RAN RPH SDZ SNS TAR WSP A AA Pharma Inc. Actavis Pharma Company Apotex Inc. AstraZeneca Canada Inc. B Bristol-Myers Squibb Boehringer Ingelheim (Canada) Ltd. H Hospira Healthcare Corporation J Jamp Pharma Corporation M Mylan Pharmaceuticals ULC O Odan Laboratories Ltd. P Pharmascience Inc. Pendopharm Inc. Purdue Pharma R Ranbaxy Pharmaceuticals Canada Inc. Ratiopharm S Sandoz Canada Inc. Sanis Health Inc. T Taro Pharmaceuticals Inc. Teva Canada Limited W Wellspring Pharmaceutical Canada Corp. X Miscellaneous Manufacturers EFFECTIVE APRIL 1,
14 APPENDIX 2 ALPHABETICAL LIST OF PHARMACEUTICAL PRODUCTS Appendix 2: Alphabetical List of Pharmaceutical Products Product Name Page Product Name Page NUMERIC 0.9% SODIUM CHLORIDE % DEXT/ 0.3% NACL (2/3-1/3) % DEXT/0.3% NACL/20 MEQ KCL % DEXT/0.3% NACL/40 MEQ KCL % DEXTROSE (D5W) % DEXTROSE/ 0.15% KCL 20 MEQ % DEXTROSE/ 0.3% KCL 40 MEQ... 2 A APO-BISACODYL... 2 APO-DOCUSATE SODIUM... 3 APO-FENTANYL APO-FENTANYL APO-FENTANYL APO-FENTANYL B BISACODYL... 2 BUPIVACAINE HCL... 4 BUPIVACAINE HCL/ EPINEPHRINE BITARTRATE... 4 C CALAX... 2 CO FENTANYL... 1 COLACE... 3 D DOCUSATE CALCIUM... 2 DOCUSATE SODIUM... 3 DULCOLAX... 2 E ENEMOL... 3 F FENTANYL... 1 FENTANYL CITRATE... 2 J JAMP SENNAQUIL... 3 JAMP-DOCUSATE CALCIUM... 2 JAMP-SENNA... 3 L LACTATED RINGER'S... 2 LAX-A-DAY... 3 M MEGACE OS... 1 MEGESTROL... 1 MEGESTROL ACETATE... 1 MYLAN-FENTANYL MATRIX... 1 N NOVO-DOCUSATE CALCIUM... 2 NOVO-DOCUSATE SODIUM... 3 P PARENTERAL SOLUTIONS (LARGE & SMALL VOL). 2 -BISACODYL DOCUSATE CALCIUM DOCUSATE SODIUM FENTANYL MTX SENNOSIDES... 3 POLYETHYLENE GLYCOL POTASSIUM CHLORIDE... 2 POTASSIUM CHLORIDE (K+)... 2 R RAN-FENTANYL MATRIX... 1 RATIO-DOCUSATE SODIUM... 3 S SANDOZ FENTANYL PATCH... 1 SELAX... 3 SELAX SENNATAB... 3 SENNOSIDES... 3 SENNOSIDES/ DOCUSATE SODIUM... 3 SENOKOT... 3 SENOKOT S... 3 SENSORCAINE... 4 SENSORCAINE WITH EPINEPHRINE... 4 SODIUM CHLORIDE... 2 SODIUM PHOSPHATE/ SODIUM ACID PHOSPHATE 3 SOFLAX... 3 EFFECTIVE APRIL 1,
15 APPENDIX 2 ALPHABETICAL LIST OF PHARMACEUTICAL PRODUCTS Product Name Page Product Name Page T A-DOCUSATE CALCIUM... 2 A-DOCUSATE SODIUM... 3 A-FENTANYL... 1 EFFECTIVE APRIL 1,
16 APPENDIX 3 NUMERICAL LIST BY DRUG IDENTIFICATION NUMBER DRUG IDENTIFICATION NUMBERS OF PHARMACEUTICAL PRODUCTS DIN Page DIN Page EFFECTIVE APRIL 1,
Updates to the Alberta Human Services Drug Benefit Supplement
Updates to the Alberta Human Services Drug Benefit Supplement Effective December 1, 2014 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone
Updates to the Alberta Human Services Drug Benefit Supplement
Updates to the Alberta Human Services Drug Benefit Supplement Effective January 1, 2016 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone
Information for Vermont Prescribers of Prescription Drugs (Long Form)
The information on this form is provided pursuant to Vermont law 33 V.S.A. section 2005a which requires this disclosure by pharmaceutical marketers. Information for Vermont Prescribers of Prescription
Updates to the Alberta Drug Benefit List. Effective January 1, 2016
Updates to the Alberta Drug Benefit List Effective January 1, 2016 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
Auvi-Q (epinephrine injection) 0.15mg and 0.3mg (Sanofi)
Auvi-Q (epinephrine injection) 0.15mg and 0.3mg (Sanofi) On Oct. 28, 2015, Sanofi recalled all lots (numbered between 2299596 and 3037230; expiring between March 2016 and December 2016) of both strengths
SECTION 3. Criteria for Special Authorization of Select Drug Products. Section 3 Criteria for Special Authorization of Select Drug Products
SECTION 3 Criteria for Special Authorization of Select Drug Products Section 3 Criteria for Special Authorization of Select Drug Products CRITERIA FOR SPECIAL AUTHORIZATION OF SELECT DRUG PRODUCTS The
Community Pharmacists in NHS Rotherham
SERVICE LEVEL AGREEMENT TO ENABLE COMMUNITY PHARMACISTS IN NHS ROTHERHAM TO PROVIDE PALLIATIVE CARE DRUGS AS LOCAL ENHANCED SERVICE PREPARED BY: NHS Rotherham CCG Medicines Management Team on behalf of
Updates to the Alberta Drug Benefit List. Effective March 1, 2015
Updates to the Alberta Drug Benefit List Effective March 1, 2015 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370
Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013
Berkshire Healthcare NHS Foundation Trust Becky White CHS Pharmacist April 2013 Access to palliative care drugs out of hours Agreement set up with local community pharmacy s to hold stock of commonly prescribed
NO-COST PREVENTIVE CARE DRUGS
NO-COST PREVENTIVE CARE DRUGS INFORMATION FOR NON-GRANDFATHERED ASO GROUPS The Affordable Care Act (ACA) requires that certain preventive care drugs and drug categories be covered at no cost to health
SPECIAL AUTHORIZATION GUIDELINES
91B ALBERTA DRUG BENEFIT LIST SPECIAL AUTHORIZATION GUIDELINES 37BSpecial Authorization Policy 90BDrug Products Eligible for Consideration by Special Authorization Drug Products may be considered for coverage
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES HEAD AND NECK ONCOLOGY NURSING FOR HEAD AND NECK CANCERS Head & Neck Site Group Oncology Nursing for Head and Neck Cancers Specialized Oncology
Pharmacist Administration of Publicly Funded Influenza Vaccine and Claims Submission using the Health Network System
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Pharmacist Administration of Publicly Funded Influenza Vaccine and Claims Submission using the Health Network System For the 2012-2013
Patient Eligibility: Ontarians who are five years of age and older that have a valid Ontario Health Card.
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Pharmacist Administration of Publicly Funded Influenza Vaccine and Claims Submission using the Health
A pharmacist s guide to Pharmacy Services compensation
Alberta Blue Cross Pharmaceutical Services A pharmacist s guide to Pharmacy Services compensation 83443 (2015/12) GENERAL DESCRIPTION... 3 Details... 3 ASSESSMENT CRITERIA... 3 Assessment for a Prescription
RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS
RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS After the completion of this module you will be able to: Define medication reconstitution. Read a medication label. Reconstitute a medication. Calculate
Narcotic drugs used for pain treatment Version 4.3
Narcotic drugs used for pain treatment Version 4.3 Strategy to restrict the pack sizes or the type of packaging available in public pharmacies. 1. Introduction The document describing the strategy of the
BRIEFING 7 LABELING DEFINITION
Page 1 of 10 BRIEFING 7 Labeling. This general chapter provides definitions and standards for labeling of official articles. Note that, as with compendial quality standards, labeling requirements also
AETNA BETTER HEALTH Over the counter (OTC) product list
TOPICAL ANTIBACTERIAL/ANTIFUNAL OTC DRUGS OTC bacitracin topical ointment OTC clotrimazole (vaginal use) OTC clotrimazole (topical use) OTC miconazole 2% ointment OTC miconazole vaginal suppositories,
OPIOIDS CONVERSION GUIDELINES 2007
Opioid analgesics vary in potency, side effect and pharmacokinetic profile. Therefore the Opioid Conversion Guidelines has been developed to assist when changing opioid drug therapy. When opioid rotating
Reducing Narcotics Misuse and Abuse in Workers Compensation
Reducing Narcotics Misuse and Abuse in Workers Compensation Trusted. Reliable. Sustainable. Page 2 Introduction Narcotics have a long history of being used to therapeutically treat pain resulting from
Service Specification for NHS Community Pharmacy Palliative Care Drugs Stockist Scheme
Service Specification for NHS Community Pharmacy Palliative Care Drugs Stockist Scheme 1. This agreement is between NHS England North Midlands (Derbyshire/ Nottinghamshire only) (the Commissioner) Birch
INR: RUPTURED ANEURYSM: POST EMBOLIZATION Patient Identification Page 1 of 5. Allergies: Weight: kg Diagnosis:
Page 1 of 5 Allergies: Weight: kg Diagnosis: Service: Admission Admit to Inpatient Admit to Daypatient Place on Outpatient Observation Status Hospital Attending: Attending Physician Attending Provider:
Pharmacy Technician Training Program. Minimum Competencies
1. Pharmacy Practice Pharmacy Technician Training Program Minimum Competencies 1.1 The candidate shall be familiar with the mission of pharmacy and the various permitted pharmacy practice sites. The candidate
SECTION 2. Section 2 Multiple Sclerosis (MS) Drug Coverage
SECTION 2 Multiple Sclerosis (MS) Drug Coverage Section 2 Multiple Sclerosis (MS) Drug Coverage ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST Selected Drug Products used in the treatment of patients with
DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES
Serving the people of north east Essex DRUG CALCULATIONS FOR REGISTERED NURSES ADULT SERVICES A Programmed Approach - It is essential you read this pack & practice the questions prior to your drug calculation
Section 2 Solving dosage problems
Section 2 Solving dosage problems Whether your organization uses a bulk medication administration system or a unit-dose administration system to prepare to administer pediatric medications, you may find
Documentation Summary for Chemotherapy Administration, Nonchemotherapy Injections and Infusions
Documentation Summary for Chemotherapy Administration, Nonchemotherapy Injections and Infusions Documentation to Support Medical Necessity of Chemotherapy Services Date: April 23, 2012 Source Information:
Appendix 4: Guidelines for Prescribing and Administering Drugs:
Appendix 4: Guidelines for Prescribing and Administering Drugs: A midwife may prescribe and administer the following substances in accordance with the guidelines approved by the Board. This list indicates
PHARMACY TECHNICIAN COURSE DESCRIPTIONS
PHARMACY TECHNICIAN COURSE DESCRIPTIONS OCCUPATIONAL COMPLETION POINTS AND PROGRAM LENGTH: * Basic Healthcare Worker OCP A 90 Hours (COURSE #HSC 0003) * Community Pharmacy Technician OCP B 360 Hours (COURSE
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
PRESCRIBING INFORMATION PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 10 mg/ml Sandoz Canada Inc. Date of Preparation: September 1992 145 Jules-Léger Date of Revision : January 13, 2011 Boucherville, QC, Canada
SPECIAL COVERAGES. Seniors with Special Support coverage will pay the lesser of the Special Support co-payment or the $20 per prescription.
SPECIAL COVERAGES A) SENIORS DRUG PLAN As of July 1, 2015, Saskatchewan residents who are 65 years of age and older with a reported income (Line 236) that is $65,515 or less for 2013 will be eligible for
DISPENSING HIGH RISK/ALERT MEDICATIONS. Lana Gordineer, MSN, RN Diabetes Educator
DISPENSING HIGH RISK/ALERT MEDICATIONS Lana Gordineer, MSN, RN Diabetes Educator HIGH RISK/ALERT MEDICATIONS (or DRUGS) Medications that have a high risk of causing serious injury or death to a patient
Department of Human Services
Department of Human Services Proposed PDL for IOWA Medicaid Program Listing Covered OTC Drugs: Effective Date: 10/13/2015 Note: Not all s may be represented and the status of those listed are subject to
How To Take Methotrexate By Injection
How To Take Methotrexate By Injection 1 how long does it take for methotrexate to work for abortion 2 methotrexate 15 mg hair loss 3 methotrexate injection dosage for rheumatoid arthritis 4 order methotrexate
Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide
Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide Review correct procedure and precautions for the following routes of administration: Ear drops Enteral feeding tube Eye drops IM,
LESSON ASSIGNMENT. After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio and proportion method.
LESSON ASSIGNMENT LESSON 2 Pharmacology TEXT ASSIGNMENT Paragraphs 2-1 through 2-34. LESSON OBJECTIVES After completing this lesson, you should be able to: 2-1. Compute medication dosages by the ratio
PRINCIPLES OF PHARMACOLOGY. MEDICAL ASSISTANT S ROLE History: Drug Legislation & Regulation. Education: indication, instructions, side effects
PRINCIPLES OF PHARMACOLOGY Medical Assistants At the heart of health care MEDICAL ASSISTANT S ROLE History: prescription over the counter (OTC) alcohol (ETOH), recreational, smoking, herbal remedies Education:
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: Frenchay 0117 340 6692 Southmead 0117 323
A Bulletin for PHARMACY Service Providers from Alberta Blue Cross. Alberta Public Health Activities Program (APHAP)
harmacy Benefact A Bulletin for HARMACY Service roviders from Alberta Blue Cross Number 479 September 2014 Alberta ublic Health Activities rogram (AHA) As in past years, pharmacists are invited to participate
supplement 18 PAYS D'ORIGINE NOM DOSAGE FORME NR ST LABORATOIRE 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 1VIAL
supplement 18 NOM DOSAGE FORME NR ST LABORATOIRE PAYS D'ORIGINE ACTEMRA 80MG/4ML 4ML CONCENTRATE FOR SOLUTION FOR INFUSION x 218156/09 * CHUGAI PHARMA MANUFACTURING CO LTD FOR F.HOFFMANN-LA ROCHE LTD -
Resolving Concerns Within Alberta s Health System
Resolving Concerns Within Alberta s Health System C O N T E N T S Abuse...2 Alberta Blue Cross Drug Plan...3 Alberta Health Care Insurance Plan...3 Alberta s Health System...3 Alberta Ombudsman...4 Ambulance
product list Put our quality and service behind your brand. 200 Hicks Street, Westbury, NY 11590 +1.516.986.1700
product list We are committed to high quality and expedited service, bringing leading and exclusive products to our customers. Our private label products include a broad range of pharmaceutical categories.
Basic Medication Administration Exam RN (BMAE-RN) Study Guide
Basic Medication Administration Exam RN (BMAE-RN) Study Guide Review correct procedure and precautions for the following routes of administration: Ear drops Enteral feeding tube Eye drops IM, subcut injections
ELECTROLYTE SOLUTIONS (Continued)
ELECTROLYTE SOLUTIONS (Continued) Osmolarity Osmotic pressure is an important biologic parameter which involves diffusion of solutes or the transfer of fluids through semi permeable membranes. Per US Pharmacopeia,
Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)
Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3) List the different medication effects (p5) List the ways that medications
PPP 1. Continuation of a medication to ensure continuity of care
PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The
SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary
November 1, 2014 Bulletin #150 ISSN 1923-0761 SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary New Exception Drug Status (EDS) Listings Effective November 1, 2014
- - - β a The Tox 21 programme is pooling federal resources to use robotics technology to screen thousands of chemicals for potential toxicity, using screening data to predict the potential toxicity of
GENERAL INFORMATION. With Express Scripts, you have access to:
CONTENTS GENERAL INFORMATION... 1 PREFERRED DRUG LIST....2 PHARMACIES... 3 PRESCRIPTIONS... 4 GENERIC AND PREFERRED DRUGS... 5 EXPRESS SCRIPTS WEBSITE AND MOBILE APP... 5 SPECIALTY MEDICATIONS... 6 PRIOR
Abstral Prescriber and Pharmacist Guide
Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of
Dilution and. Concentration. Chapter 10 TERMS OBJECTIVES % C 4 5 6 X
Chapter 10 Dilution and TERMS % C 7 8 9. 4 5 6 X Alligation Alligation alternate Alligation medial Diluent Stock solution Concentration OBJECTIVES Upon completion of this chapter, the technician student
Hospital Outpatient Coding and Billing Information Sheet for Neulasta and NEUPOGEN
Hospital Outpatient Coding and Billing Information Sheet for Neulasta and Neulasta Delivery Kit Neulasta Prefilled Syringe For assistance contact 1-844-MYNEULASTA (1-844-696-3852) or visit www.amgenassistonline.com
The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program
Subject: Important Drug Warning Announcement of a single shared REMS (Risk Evaluation and Mitigation Strategy) program for all Transmucosal Immediate Release Fentanyl (TIRF) products due to the potential
Bayer HealthCare Patient Assistance Program. Program Guidelines & Application Form
Program Guidelines & Application Form PROGRAM GUIDELINES The provides medication (listed below) for those in need, who have no prescription drug coverage and limited financial resources. All applications
Autism Spectrum Disorder Formulation & Resource Guide
Autism Spectrum Disorder Formulation & Resource Guide Autism Spectrum Disorder Formulation & Resource Guide Knowledge Changes Everything: Quality. Innovation. Experience. Since 1974. 2015 College Pharmacy
Tutorial 4 SOLUTION STOICHIOMETRY. Solution stoichiometry calculations involve chemical reactions taking place in solution.
T-27 Tutorial 4 SOLUTION STOICHIOMETRY Solution stoichiometry calculations involve chemical reactions taking place in solution. Of the various methods of expressing solution concentration the most convenient
OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013
Introduction OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 In 2007, Attorney General Wasden filed lawsuits against 33 pharmaceutical companies for
Labelling and Packaging: An Aggregate Analysis of Medication Incident Reports Project Report
Labelling and Packaging: An Aggregate Analysis of Medication Incident Reports Project Report Institute for Safe Medication Practices Canada Institut pour l utilisation sécuritaire des médicaments du Canada
NOTICES DEPARTMENT OF HEALTH
NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [43 Pa.B. 3060] [Saturday, June 1, 2013] Under 28 Pa. Code 1005.11 (relating to drug use, control and security), the following drugs
PHARMACEUTICAL MANAGEMENT PROCEDURES
PHARMACEUTICAL MANAGEMENT PROCEDURES THE FORMULARY The purpose of Coventry Health Care s formulary is to encourage use of the most cost-effective drugs. The formulary is necessary because the cost of prescription
Product Information: Jevity 1.5 Cal
Product Information: Jevity 1.5 Cal 1 of 5 JEVITY 1.5 CAL is a calorically dense formula with a unique fiber blend that provides Complete, Balanced Nutrition. For tube feeding. For supplemental or sole-source
Rx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
Compensation Plan for Pharmacy Services
Compensation Plan for Pharmacy Services Attachment A Section 1 - Definitions ABC Pharmacy Agreement means an agreement between ABC and a Community Pharmacy as described in Schedule 2.1 of the Alberta Blue
An introduction to High Risk Medications
An introduction to High Risk Medications Une politique sure des médicaments : déjà deux approches 25 octobre 2013 Danguy Christine Hôpital A. Vésale An introduction to High Risk Medications 1. High Risk
PHARMACEUTICAL EXCIPIENTS
PHARMACEUTICAL EXCIPIENTS Brian R Matthews PDA Bethesda, MD, USA DHI Publishing, LLC River Grove, IL, USA 10 9 8 7 6 5 4 3 2 1 ISBN: x-xxxxxx-xx-x Copyright 2005 Brian R Matthews. All rights reserved.
48 th Annual Meeting. New and Uncommon Drugs. Safety Stat. Medication Error Stats. Disclosure. Objectives. New Oral Anticoagulants 8/3/2014
48 th Annual Meeting Safety Stat New and Uncommon Drugs Alexis Berndt, PharmD, BCPS There is a one in 1,000,000 chance of a traveller being harmed while in an aircraft. In comparison, there is a one in
Suprax Film Tablet 400 Mg 10 Tb
Suprax Film Tablet 400 Mg 10 Tb suprax 200mg 5ml suspension average price of suprax suprax cost walgreens cost of suprax suspension suprax third generation suprax cefixime tablets suprax coupon lupin cefixime
FUNDS ADMINISTRATIVE SERVICE INC.
FUNDS ADMINISTRATIVE SERVICE INC. CLIENT PORTAL UNION MEMBER USER GUIDE Table of Contents INTRODUCTION... 1 OUR WEBSITE... 1 ACCESSING INFORMATION SPECIFIC TO YOU AND YOUR FAMILY... 2 ACCOUNT INFORMATION...
1 Manipulation of formulae and dilutions
1 Manipulation of formulae and dilutions This first chapter of questions is specifically designed to cover a range of numeracy skills. It will give the user further experience in the skills of addition,
Welcome to the LILETTA Patient Savings Program
Welcome to the LILETTA Patient Savings Program Eligible insured patients, activate your card today* * See full program Terms and Conditions on page 3 of this brochure or at LILETTAcard.com. Help With Your
Pharmaceutical Waste Management Program St. Joseph Mercy Oakland. Pharmacy/Patient Care
Pharmaceutical Waste Management Program St. Joseph Mercy Oakland Pharmacy/Patient Care Objectives Understand the background and regulatory requirements Identify pharmaceutical waste and how to dispose
Drugs to consider prescribing by brand name or where brands should not be switched
Index Page Index Page Adrenaline (epinephrine) prefilled syringes 2 Hormone replacement therapy oral 3 Alprostadil injection 4 Human papillomavirus vaccine 5 Aminophylline modified release 2 Insulins 3
DRUG CALCULATIONS. Mathematical accuracy is a matter of life and death. [Keighley 1984]
![DRUG CALCULATIONS. Mathematical accuracy is a matter of life and death. [Keighley 1984]](/thumbs/39/19297070.jpg "DRUG CALCULATIONS. Mathematical accuracy is a matter of life and death. [Keighley 1984]")
DRUG CALCULATIONS Mathematical accuracy is a matter of life and death. [Keighley 1984] At the end of this practice sheet, you will be able to: Perform simple arithmetical tasks. Accurately calculate drug
Product Information: Jevity 1.5 Cal
Product Information: Jevity 1.5 Cal 1 of 5 JEVITY 1.5 CAL is a calorically dense formula with a unique fiber blend that provides Complete, Balanced Nutrition. For tube feeding. For supplemental or sole-source
EDUCATOR S LESSON PLAN
EDUCATOR S LESSON PLAN Pharmacy Technician Training Program Student Version Orientation Orientation introduces the student to basic terms and definitions. An introduction to the Pharmacy Technician Certification
PRODUCT LIST BY THERAPEUTICS
Jaapharm Canada Inc. 510 Rowntree Dairy Road, Building J, Woodbridge, Ontario, Canada L4L 8H2 Tel.: 905-851-7885 Canada/USA: 1-800-465-9587 Fax: 905-856-5838 Canada/USA: 1-888-606-4777 Email: info@jaapharm.com
National Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment
NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient
Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company
Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company PRESCRIPTION DRUG RIDER This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health
D( desired ) Q( quantity) X ( amount ) H( have)
Name: 3 (Pickar) Drug Dosage Calculations Chapter 10: Oral Dosage of Drugs Example 1 The physician orders Lasix 40 mg p.o. daily. You have Lasix in 20 mg, 40 mg, and 80 mg tablets. If you use the 20 mg
PharmaCare is BC s public drug insurance program that assists BC residents in paying for eligible prescription drugs and designated medical supplies.
PHARMANET AND PHARMACARE DATA DICTIONARY Date Range: September 1, 1995 to present date, data is provided by calendar year Data Source: BC Ministry of Health Description The PharmaNet system is an online,
Note that the following document is copyright, details of which are provided on the next page.
Please note that the following document was created by the former Australian Council for Safety and Quality in Health Care. The former Council ceased its activities on 31 December 2005 and the Australian
Position Classification Standard for Pharmacy Technician Series, GS-0661
Position Classification Standard for Pharmacy Technician Series, GS-0661 Table of Contents SERIES DEFINITION... 2 SERIES COVERAGE... 2 EXCLUSIONS... 4 TITLES... 4 NOTES TO USERS OF THIS STANDARD... 5 CLASSIFICATION
Drug Dosage Practice Problems
Drug Dosage Practice Problems Topics covered: Metric Conversions ---------------------------------------------------------------- pg 2 General Conversions --------------------------------------------------------------
Alberta Health. Alberta Health Care Insurance Plan Statistical Supplement
Alberta Health Alberta Health Care Insurance Plan Statistical Supplement 2012 2013 Contact Information For inquiries concerning material in this publication contact: Alberta Health Health Benefits and
Manufacturer of drug substance
Original s and Biosimilars (marketing authorizations in the EU) Date: January 2016 1) Somatropin s ORIGINAL PRODUCTS: Authorization Genentech Genotropin Somatropin Pharmacia/ Pfizer E. coli Humatrope Somatropin
NDC Reporting Requirements in Health Care Claims Version 1.1 October 28, 2014
WEDI Strategic National Implementation Process (SNIP) Transactions and Code Sets Workgroup 837 Subworkgroup NDC Reporting White Paper NDC Reporting Requirements in Health Care Claims Version 1.1 October
Hospice & Palliative Care in Developing Countries
Hospice & Palliative Care in Developing Countries Compounding End of Life Medications WHO Recommendations to Developing Countries Russ Zakarian, Pharm.D. FASCP What is Compounding? Compounding is the method
PATIENT APPLICATION FORM INSTRUCTIONS
INSTRUCTIONS The Safety Net Foundation is a nonprofit patient assistance program that helps qualifying uninsured patients access Amgen medicines at no cost. To apply online, access program information
April 10, 2008 Montana Healthcare Programs Update
April 10, 2008 Montana Healthcare Programs Update THE FOLLOWING INFORMATION UPDATES AND REPLACES THE PROVIDER NOTICE DATED MARCH 10, 2008. NEW OR REVISED INFORMATION IS MARKED WITH A CHANGE BAR IN THE
By Lawrence A. Trissel, B.S., R.Ph., FASHP. Modified from the original presentation March 9, 2006
USP Chapter : Beyond Use Dating, Stability, and Storage Modified from the original presentation March 9, 2006 By Lawrence A. Trissel, B.S., R.Ph., FASHP Supported by an unrestricted educational grant
Decentralised Procedure. Public Assessment Report. Paracetamol-ratiopharm 10 mg/ml Infusionslösung Paracetamol DE/H/1908/001/DC
Bundesinstitut für Arzneimittel und Medizinprodukte Decentralised Procedure Public Assessment Report Paracetamol-ratiopharm 10 mg/ml Infusionslösung Paracetamol DE/H/1908/001/DC Applicant: TEVA Pharma
Care Guide: Cancer Pain
Care Guide: Cancer Pain Key Points: Cancer Pain Specific Pain Problems 1. Pain is defined as an independent and emotional experience associated with actual or potential tissue damage or described in terms
Pharmacy Technician Web Based Calculations Review
Pharmacy Technician Web Based Calculations Review MODULE 3 3 2009 PRESENTED BY: Jenifer Maki, JENIFER PharmD MAKI, PHARMD BRETT SALEM, PHARMD WITH CONTRIBUTIONS DEREK LOMAS, FROM: PHARMD Brett Salem, PharmD
Order Phenytoin dilantin ivpb rate when to order phenytoin level dilantin 30 mg
Order Phenytoin 1 dilantin loading dose iv 2 can you buy dilantin 3 generic phenytoin manufacturers 4 what is a high dilantin level 5 buy generic dilantin 6 dilantin ivpb administration 7 purchase phenytoin
Summary of New Plans and Plan Sponsor changes Effective January 1, 2011
Medco Health Solutions, Inc. 100 Parsons Pond Drive Franklin Lakes, NJ 07417 www.medco.com/rph Summary of New Plans and Plan Sponsor changes Effective January 1, 2011 New Plan Sponsors Plan sponsor: See
Alberta Health Care Insurance Plan Essential Information for Albertans
Essential Information for Albertans The Alberta Health Care provides eligible residents of Alberta and their dependants with: coverage for insured services provided by physicians in Alberta and in other
Alberta Health. Alberta Health Care Insurance Plan Statistical Supplement
Alberta Health Alberta Health Care Insurance Plan Statistical Supplement 2013 / 2014 Contact Information For inquiries concerning material in this publication contact: Alberta Health Health System Accountability
Contents General Information... 1. General Information
Contents General Information... 1 Preferred Drug List... 2 Pharmacies... 3 Prescriptions... 4 Generic and Preferred Drugs... 5 Express Scripts Website and Mobile App... 5 Specialty Medicines... 5 Prior